GM-CSF can attract immune cells to tumors, activate macrophage and dendritic cells, and enhance tumor-antigen presentation— features that have resulted in its incorporation into oncolytic viruses and anti-cancer vaccines [21]. This evidence concerns the gene CSF2 and neoplasm.